Disease Info Card

Chemotherapy-induced Nausea And Vomiting

Information about Chemotherapy-induced Nausea And Vomiting: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Chemotherapy-induced Nausea And Vomiting

Most recent studies have shown that Chemotherapy-induced Nausea And Vomiting shares some biological mechanisms with anxiety-disorders, constipation, diarrhea, headache, lung-neoplasms, malignant-neoplasm-of-breast, malignant-neoplasm-of-lung, malignant-neoplasms, mammary-neoplasms, motion-sickness, nausea, nausea-and-vomiting, neoplasms, pain, postoperative-nausea, postoperative-nausea-and-vomiting, retching, vomiting, vomiting-anticipatory.

Among the many pathways, these few ones have gauged particular interests from scientists studying Chemotherapy-induced Nausea And Vomiting, and have been seen in publications frequently: Aging, Anaphylaxis, Cell Growth, Cognition, Conjugation, Excretion, Gastric Emptying, Hypersensitivity, Liver Regeneration, Pathogenesis, Receptor Internalization, Reflex, Regeneration, Response To Stress, Secretion, Sensitization, Sensory Perception, Translation, Transport

Quite a number of genes have been found to play important roles in Chemotherapy-induced Nausea And Vomiting, such as ASAH1, B3GAT1, CD160, CYP2C9, CYP2D6, CYP3A4, EXOSC9, HTR3A, HTR3B, NDC80, S100A12, TAC1, TACR1, WAS. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Chemotherapy-induced Nausea And Vomiting Related Genes

click to see detail information for each gene

ASAH1 B3GAT1 CD160
CYP2C9 CYP2D6 CYP3A4
EXOSC9 HTR3A HTR3B
NDC80 S100A12 TAC1
TACR1 WAS